MedTrace Logo

Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease

NCT05865691 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2024-08-01

No results posted yet for this study

Summary

Chronic liver diseases represent a major public health problem and are responsible for more than 150,000 deaths in Europe each year. These diseases are accompanied by symptoms that profoundly alter the quality of life and mainly affect people of working age, leading to a major economic impact.

Coagulation disorders, inflammation and vascular alterations are associated with chronic liver diseases but their role in the onset and/or progression of liver diseases is still not fully understood.

A better understanding of chronic liver diseases and in particular of the factors that play a role in the onset and progression of these diseases would improve patient management and therefore have a positive impact on individuals, but also on the healthcare system and the economy.

Conditions

  • Chronic Liver Diseases
  • Coagulation

Interventions

OTHER

biomarker assay

blood sample on the day of inclusion

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Pierre Emmanuel Rautou · APHP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-07
Primary Completion
2035-10-31
Completion
2035-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05865691 on ClinicalTrials.gov